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Irritant contact dermatitis (ICD) is a frequent inflammatory skin disease induced by skin contact with low
molecular weight chemicals such as haptens endowed with proinflammatory properties. Allergic contact
dermatitis (ACD) is a frequent complication of ICD and is mediated by hapten-specific T cells primed in lymph
nodes by skin emigrating dendritic cells. The aim of this study was to analyze the relationship between ICD and
ACD to 2,4-dinitrofluorobenezene (DNFB) in C57BL/6 and BALB/C mice, which develop a severe and a moderate
skin inflammation, respectively. Upon a single skin painting with DNFB, C57BL/6 developed within hours a more
severe dose-dependent ICD response as compared to BALB/C mice, which was associated with enhanced
upregulation of IL-1b, IL-6, and IL-10. Skin exposure to a low dose of DNFB resulted, in both strains, in a low ICD
that resolved in a few hours. Alternatively, skin painting with either an intermediate or a high DNFB
concentration induced an ICD that subsequently gave rise to an ACD reaction whose intensity was proportional
to the magnitude of the ICD response and was more severe in C57BL/6 mice than in BALB/C mice. In conclusion,
the hapten-induced skin contact irritation conditions the development and the severity of ACD.
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INTRODUCTION
Contact dermatitis (CD) is a frequent inflammatory skin
disease induced by skin exposure to low molecular weight
chemicals, endowed with both proinflammatory and anti-
genic properties (Rowland et al., 2001; Saint-Mezard et al.,
2004b). Through their proinflammatory properties, haptens
generate a non-antigen-specific skin inflammation also
known as irritant contact dermatitis (ICD) (Basketter et al.,
1999). Following contact with the skin, haptens cause
activation of skin cells resulting in the rapid production of a
whole array of inflammatory cytokines (including IL-1b, IL-6,
and TNF-a) and chemokines (including CCL20) involved the
recruitment and activation of dendritic cell (DC) precursors
and in the migration of skin DC to draining lymph nodes
(LNs) (for review see Pastore et al., 2004; Saint-Mezard et al.,
2004b). In addition, haptens become immunogenic after
covalent binding to discrete amino-acid residues of proteins
and by generating modified self-proteins to induce allergic
contact dermatitis (ACD) (Lepoittevin and Leblond, 1997;
Smith Pease et al., 2003). ACD, also referred to as contact
sensitivity is a delayed-type hypersensitivity reaction
mediated by hapten-specific T cells, which are primed in
LNs and recruited in the skin during the afferent and efferent
phase of the reaction, respectively (Blauvelt et al., 2003;
Saint-Mezard et al., 2004b). Upon skin contact, the hapten is
taken up by immature skin DCs which migrate from the skin
to the paracortical area of draining LNs, where they prime
hapten-specific T cells through presentation of hapten–
protein complexes on major histocompatibility complex
molecules (Bour et al., 1995; Krasteva et al., 1998). A
subsequent skin challenge with the same hapten leads to the
rapid recruitment of effector T cells in the skin, that initiate
inflammation via induction of keratinocyte apoptosis (Bour
et al., 1995; Kehren et al., 1999). We and others have
demonstrated that ACD to the strong hapten 2,4-dinitrofluoro-
benzene (DNFB) in mice is mediated by CD8þ cytotoxic T
cells and downregulated by CD4þ T cells (Gorbachev and
Fairchild, 2001; Girolomoni et al., 2004; Saint-Mezard et al.,
2004a).
Clinical evidence supports the hypothesis that ICD
promotes the development of ACD and conditions its severity
(Uter et al., 2005). Furthermore, it is widely accepted that the
susceptibility of individuals to develop ACD directly corre-
lates with the proinflammatory properties of haptens (Smith
et al., 2002). The severity of ACD can greatly vary from a
mild and transient skin inflammation with pruritus and
redness only to a severe long lasting exudating dermatitis.
Factors which control the severity of ACD include the nature
of haptens (ranging from strong to weak sensitizers), their
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concentrations and the conditions of exposure, most of ACD
responses being observed in occupational settings (Kimber
et al., 2003). Indeed, haptens comprise very diverse
chemicals, including a limited number of strong contact
sensitizers able to sensitize more than 90% of naive
individuals after a single skin contact and thousands of weak
haptens that can induce sensitization in a small proportion of
individuals only (occupational disease) (Diepgen and Kanerva,
2006; Pierard-Franchimont et al., 2006). Although the ability
of a given hapten to induce ACD is linked to its antigenicity, its
intrinsic proinflammatory property is essential for efficient
priming of specific T-cell precursors (Enk and Katz, 1992; Flint
et al., 1998; Le Borgne et al., 2006; personal data). It has been
known for nearly 40 years that irritation/inflammation can
enhance ACD responses. Experimental studies in guinea-pig
models (Magnusson and Kligman, 1969) as well as in human
maximization tests (Kligman, 1966) have shown that co-
administration of adjuvants or irritants with haptens could
markedly increase the hapten-induced ACD reaction. How-
ever, evidence that the quality and magnitude of the ACD
reaction depends on the nature and strength of the inflamma-
tory signals delivered by haptens during the course of ICD
reactions is still lacking.
Here, we investigated the relationship between ICD and
ACD reactions in C57BL/6 (B6) and BALB/C (BALB) mice,
which develop a severe or mild skin inflammation to DNFB,
respectively. We used the model of primary contact
hypersensitivity induced by a single DNFB painting on the
ear (Saint-Mezard et al., 2003). In this model, persistence of
the hapten in the skin for several days leads within 6 days to
the development of hapten-specific T cells which can
infiltrate the sensitized skin site and induce a contact
hypersensitivity reaction. Therefore, in primary contact
hypersensitivity, the magnitude of the skin inflammation at
day 6 depends solely on the antigenic and proinflammatory
signals delivered by hapten exposure at day 1, allowing a
direct comparison of both ICD and ACD responses in
different strains of mice. We show that ICD responses are
dose-dependent and much higher in B6 than in BALB mice.
More importantly, the intensity of the ACD reaction is
correlated to that of the ICD response, demonstrating that
the hapten-induced skin contact irritation conditions the
development and the severity of ACD.
RESULTS
ICD responses are more severe in C57BL/6 mice than in BALB/
C mice
Different doses of DNFB (0.1, 0.3, or 0.5%) applied onto the
ear induced an ICD reaction manifested by ear swelling,
which developed within 1 hour after DNFB painting in both
BALB and B6 mice. The ICD reaction was dose dependent
and presented as a mild, moderate and severe skin
inflammation in response to low, intermediate and high
DNFB concentrations, respectively (Figure 1a and b). The
ICD reactions were dramatically higher in B6 (Figure 1b) than
in BALB mice (Figure 1a). Indeed, at each DNFB concentra-
tion, ear swelling was 3-fold higher in B6 skin as compared to
BALB mice. Thus, the skin of B6 mice seems to be more
sensitive to the proinflammatory effects of DNFB than that of
BALB mice.
The peak and the kinetics of the ICD reaction varied
between the two strains. In BALB mice, the ICD peaked
between 1 and 3 hours irrespective of the dose and decreased
thereafter. Alternatively, in B6 mice, only low DNFB
concentration induced an ICD reaction with a peak at 1 hour;
intermediate and high concentrations of DNFB resulted in an
ICD peak delayed at 3–6 hours with persistence of the skin
inflammation up to 24 hours after sensitization.
Histological analysis of 0.3% DNFB-treated ears at 6 hours
after skin painting confirmed that the skin inflammation, as
revealed by dermal edema and cell infiltration in the dermis,
was more pronounced in B6 (Figure 1f) than in BALB mice
(Figure 1e).
Collectively these results show that B6 mice have a ‘‘high
ICD responder’’ status whereas BALB mice have a ‘‘low ICD
responder’’ status.
The severity of ICD correlates with high levels of IL-1b/IL-6
mRNA and low levels of IL-10 mRNA
To get better insights into the molecular mechanisms
involved in the development of ICD reactions we next
analyzed, by RNA protection assay, the expression of
proinflammatory (IL-1a, IL-1b, and IL-6) and anti-inflam-
matory (IL-10) cytokines in the ear skin, 3 hours after skin
exposure to DNFB. The ear skin of naive and vehicle-treated
BALB mice contained only trace amounts of IL-1a, IL-1b,
IL-6, and IL-10 messenger RNA (mRNA) (Figure 2). DNFB
sensitization induced a dose-dependent upregulation of both
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Figure 1. Skin contact irritation is more severe in C57BL/6 mice than in
BALB/C mice. A single skin painting with 0.1% (}), 0.3% (&) or 0.5% (W)
DNFB on the left ear (and vehicle on the right ear) of (a) BALB/C (white) and
(b) C57BL/6 (black) mice induced within hours an immediate ear skin
inflammation. Results are expressed as the mean ear swelling7SD.
(c–f) Histological analysis of ear sections from BALB/C and C57BL/6 mice,
6 hours after vehicle (c, d) or DNFB (e, f) sensitization. Hematoxylin and eosin
staining. Original magnification  100. Results are representative of three
independent experiments.
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IL-1b and IL-6 (Figure 2b) with a 2- and 4-fold increase in the
levels of both cytokines induced by 0.3 and 0.4% DNFB,
respectively, as compared to 0.1% DNFB. IL-10 mRNA
upregulation was lower than that of IL-1b and IL-6. No
significant upregulation of IL-1a mRNA was observed at any
DNFB concentration (Figure 2a). Similar upregulation of IL-
1b and IL-6, and too a lesser extend of IL-10, was found in
DNFB-painted B6 mice (data not shown). These results show
that in both mouse strains, the intensity of ICD is correlated
with the production of IL-1b and IL-6 by skin cells.
Next, we compared the levels of IL-1b and IL-10 in the
skin of B6 and BALB mice at 3 and 6 hours after DNFB
painting. The high ICD responder B6 mice produce twice
more IL-1b mRNA than BALB mice (Figure 2c). Alternatively,
expression of IL-10 mRNA was consistently higher in the low
ICD responder BALB as compared to B6 mice (Figure 2d).
These results suggest that the differential production of pro-
and anti-inflammatory cytokines may explain the differences
in the intensity of ICD reactions observed in B6 and BALB
mice.
The intensity of ICD reaction dictates the severity of ACD
responses
Mice were sensitized by DNFB and ear swelling was
measured the following hours (for ICD) and every day from
day 4 until day 16 (for ACD). As previously observed, B6
mice developed a more intense dose-dependent ICD as
compared to BALB mice (Figure 3a and b, left panel). In both
strains, intermediate and high DNFB concentrations induced
typical ACD responses characterized by bell-shaped ear
swelling curves, which peaked between day 6 and 8
depending on the hapten concentration and on the mouse
strain (Figure 3a and b, right panel). Downregulation of ACD
reaction started at day 9 and was almost complete by day 16.
For each mouse strain, the intensity of ACD reactions was
proportional to the concentration of DNFB used for
sensitization and therefore directly correlated to the magni-
tude of the ICD reaction. Consequently, B6 mice developed
more severe ACD reactions than BALB mice. Of note, a low
DNFB concentration was responsible for an early ICD
reaction but was unable to induce an ACD reaction
irrespective of the mouse.
As we have previously shown that the ACD is mediated by
IFN-g-producing CD8þ T cells primed in draining LNs and
recruited in the skin (Kehren et al., 1999), we next analyzed
the T-cell response in the skin and auricular draining LNs of
B6 and BALB mice sensitized with DNFB. We observed a
direct correlation between (i) the severity of the ICD reaction,
(ii) the numbers of DNFB-specific CD8þ T cells in LNs
(enzyme-linked immunosorbent spot assay), (iii) the magni-
tude of the recruitment of IFN-g-producing CD8þ T cells
(RT-PCR analyses), and (iv) the intensity of ACD at day 6 (data
not shown).
DISCUSSION
This study shows that the development and severity of ACD
depend on the quality and magnitude of the ICD reaction.
Skin exposure to increasing doses of DNFB induced a dose-
dependent ICD, which developed as early as 1 hour after skin
painting and resolved in a few hours to a few days depending
on the DNFB concentration. More importantly, the intensity
of ACD was proportional to the concentration of DNFB used
for sensitization and therefore directly correlated to the
magnitude of the ICD reactions. B6 mice were more sensitive
than BALB mice to the proinflammatory effect of DNFB and
exhibited a 3-fold increase in both immediate ICD and late-
ACD responses.
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Figure 2. The severity of ICD correlates with high levels of IL-1b/IL-6 mRNA
and low levels of IL-10 mRNA. (a) Detection and quantification of mRNA
for IL-1a, IL-1b, IL-6, and IL-10 by RNAse protection assay in the skin of
DNFB-treated BALB/C mice 3 hours after sensitization. Controls include
expression of mRNA in the ear skin of naive mice and of vehicle-treated
mice at 3 hours. (b) Histograms representations of the relative quantities of
IL-1b (black bars), IL-6 (white bars), and IL-10 (gray bars) mRNA recovered
from the different experimental conditions, as compared to expression of
glyceraldehyde-3-phosphate dehydrogenase mRNA as reference gene.
(c, d) Comparison of the expression levels of (c) IL-1b and (d) IL-10 mRNA
levels by RNase protection assay in the skin of BALB/C (white bars)
and C57BL/6 (black bars) mice, 3 and 6 hours following 0.3% DNFB
sensitization. Controls include mRNA levels in the ear skin of naive mice
and of vehicle-sensitized mice. mRNA relative quantities were compared
with glyceraldehyde-3-phosphate dehydrogenase mRNA as standards.
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Figure 3. The intensity of ICD reaction dictates the severity of ACD
responses. DNFB-induced skin inflammation was analyzed in groups of five
(a) BALB/C and (b) C57BL/6 mice within hours (left panel) and days (right
panel) following sensitization with DNFB 0.1% (},~), 0.3% (&,’), or 0.5%
(W,m) on the left ear and vehicle on the controlateral ear. Results are
expressed as the mean ear swelling7SD. Data are representative of four
experiments.
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ICD is the clinical outcome of the rapid release of
proinflammatory cytokines in skin sites exposed to haptens
that promote local recruitment of inflammatory cells from
blood. In vivo and in vitro studies have documented that
haptens can activate skin cells and induce the production of
several cytokines including IL-1b which, by stimulating the
migration of skin DC to LNs, has a key role in sensitization.
Lack of IL-1b results in failure to initiate ACD (Enk et al.,
1993; Shornick et al., 1996; Effendy et al., 2000). Alterna-
tively, IL-10 is an important down-regulatory factor for ACD
and acts by inhibiting effector T-cell activation. Our data
confirm previous studies showing the rapid upregulation of
IL-1b, IL-6, and IL-10 by skin cells exposed to strong haptens
(Enk and Katz, 1992; Kondo et al., 1994) and further show
that the intensity of ICD is proportional to the level of IL-1b
and IL-6 transcripts, both in B6 and BALB mice. More
importantly, B6 and BALB mice, which develop severe and
mild ICD reactions, respectively, express an opposite pattern
of production of IL-1b and IL-10. The IL-1b/IL-10 ratio is
dramatically higher in B6 than in BALB mice, suggesting that
the strain differences in the intensity of ICD could rely on the
intrinsic ability of a mouse strain to produce proinflamma-
tory rather anti-inflammatory cytokines following hapten
stimulation.
Besides cytokine production, hapten sensitization leads
within a few hours to the recruitment from blood of myeloid
DC precursors and migration of immature skin DC to LNs.
We and others have recently shown that hapten-induced
recruitment of blood DC precursors into the skin dictates the
severity of ACD (Le Borgne et al., 2006; personal data).
Interestingly, we found that upon DNFB painting, more
blood-derived DC precursors are recruited from blood into
skin in the high ACD responder B6 mice as compared to the
low ACD responder BALB mice. Consequently, higher
numbers of skin emigrating DC reaching the draining LN
and enhanced numbers of effector T cells were primed in B6
mice versus BALB mice. Thus, the correlation between the
irritant properties of haptens and the magnitude of the ACD
reaction suggests that the skin recruitment of DC precursors
results from the adjuvant properties of haptens.
The initial dogma according to which immunity results
from ‘‘self non-self-discrimination’’ has recently been chal-
lenged by the ‘‘danger signal’’ model, which proposes that
the strength of inflammatory signal delivered by the
immunogen dictates the outcome of immunization on
sensitization or tolerance (Matzinger, 2002). Haptens, by
modifying self-proteins generate new antigenic motifs pre-
sented to specific T-cell precursors. However, not all haptens
are capable of sensitization after a single skin exposure and
we have reported that weak haptens such as fragrance
allergens are unable to prime ACD effector T cells (Vocanson
et al., 2006). Indeed, weak haptens can lead to sensitization
under specific conditions only, including higher and more
frequent exposures. Thus, recognition of hapten-modified
self-peptides by T cells does not preclude induction of
hapten-specific T-cell-mediated skin inflammation. Alterna-
tively, our data support that sufficient ‘‘danger signal’’
provided by haptens at the site of sensitization and
manifested by proinflammatory cytokine and chemokine
production is a prerequisite for generation of ACD. That
strong haptens are able to deliver potent danger signals to
skin innate immunity was recently demonstrated by Le
Borgne et al. (2006) who showed that DNFB behaves as an
adjuvant able to promote the priming of CD8þ T cells
specific to an irrelevant co-administered protein antigen.
Along these lines, Grabbe et al. (1996) reported that a given
hapten could promote induction of an ACD reaction in
response to a non-cross-reactive hapten. Indeed, oxazolone-
specific ACD could develop in oxazolone-sensitized mice
upon challenge with both oxazolone and (2,4,6-trinitrochlor-
obenzene TNCB) at infra-optimal doses unable to sensitize
for ACD. Our data further emphasize that the danger signal
provided by the strong hapten DNFB is dose dependent
and conditions the intensity of the ICD reaction. Indeed, the
two high DNFB concentrations (0.3 and 0.5%) induced
dose-dependent ICD leading to ACD responses, whereas the
low DNFB dose (0.1%) resulted in a mild ICD reaction,
correlated with low levels of IL-1b, unable to give rise to
an ACD response. As previously shown, decreasing further
the DNFB concentration to as low as 0.01%, a concen-
tration devoided of irritant properties, is responsible for
tolerance to DNFB, which prevents the development of
ACD to high DNFB concentrations (Maurer et al., 2003).
Collectively, these observations strongly support that the
adjuvant properties of strong haptens contribute in both ICD
and ACD and further emphasize that ‘‘danger’’ signals
depending on the intrinsic proinflammatory properties of
the hapten and on the skin sensitivity of the host are required
for induction of the initial ICD reaction that contributes to the
severity of ACD.
Although the reason why different individuals develop
severe or mild ACD reactions in response to identical hapten
stimulation is not known, our results indicate that the genetic
susceptibility to the adjuvant effect of haptens is the crucial
parameter that conditions the magnitude of ACD. B6 skin
cells appears more sensitive to the DNFB-induced inflam-
matory signals than BALB skin cells inasmuch as they
produce higher levels of IL-1b and IL-6 (Figure 2) and
increased amounts of CCL20, a chemokine involved in the
recruitment of blood DC precursors into the skin (Le Borgne
et al., 2006; personal data). In addition, the variable
susceptibility to ACD in B6 and BALB mice could be
explained by strain-dependent differences in mast cell and
macrophage functions. Indeed, following stimulation with
Toll-like receptor ligands like lipopolysaccharide, peritoneal
macrophages of B6 mice produce higher levels of TNF-a
(Watanabe et al., 2004), which induces DC migration to LNs.
In addition, mast cells were shown to contribute to ACD via
release of TNF-a and macrophage inflammatory protein-2
(Biedermann et al., 2000). At the basal state, mast cells are
more abundant in skin of B6 than of BALB mice and produce,
following UV stimulation (Hart et al., 1998) and anti-IgE
induced activation (Noguchi et al., 2005), increased levels of
immediate mediators including histamine and b-hexosami-
nidase. As histamine is involved in vasodilatation and
vasopermeation, its enhanced secretion by B6 mast cells
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may also contribute to the increased dermal edema by
allowing more efficient recruitment of blood cells, through
interaction with H1-receptors on endothelial cells.
In conclusion, our data demonstrate that the development
and severity of ACD depend on early inflammatory events
occurring within hours after sensitization and suggest that
genetic susceptibility of ACD in human may result from
differences in host sensitivity to the adjuvant effect of haptens
that could explain the diversity of clinical presentations of
ACD among patients.
MATERIALS AND METHODS
Mice
Female C57BL/6 and BALB/c mice (7–10 weeks of age) were
purchased from Charles River Laboratories (L’Arbresle, France).
Animals were left to acclimate for 1 week before entering the study.
Five mice were used per group. Mice were provided food and water
ad libidum. All experimental procedures were in accordance with
the CREEA (Comite´ re´gional d’e´thique pour l’expe´rimentation
animale) guidelines on animal welfare.
Reagents
DNFB (Sigma, Saint Quentin Fallavier, France) was diluted in
acetone:olive oil vehicle (4:1 vol/vol), freshly before application.
Assay for primary allergic contact sensitivity
The model has been described extensively elsewhere (Saint-Mezard
et al., 2003). Naive mice were sensitized at day 0 by a single
application of various doses of DNFB applied on the left ear,
whereas the same volume of vehicle was applied on the right ear. At
various time after ear sensitization, ear thickness was measured with
a spring-loaded micromiter (J15, Blet SA, Lyon, France). Ear swelling
was calculated by subtracting the initial value from the value
recorded on the corresponding time, and further subtracting any
swelling recorded for vehicle-control ear from ear swelling recorded
for the hapten-applied ear.
Histology
Ears were fixed in a 3% formalin solution for 24 hours and processed
whole through a routine 15 hours cycle to paraffin wax embedding.
Sections (4 mm) were cut using a microtome and mounted on
Superfrosts Plus slides. Sections were dried overnight at 371C. The
slides were dewaxed in Ottixs baths and staining according to
routine hematoxylin and eosin staining procedure.
mRNA extraction and multiprobe RNAse protection assays
At 3 and 6 hours after the ear painting, ear samples were collected
from vehicle and DNFB-treated mice and frozen in liquid nitrogen.
Total RNA was extracted using the RNAXEL kit (Eurobio, F-91953,
Les Ulis, France). Chemokines mRNA levels were measured by
RNase protection assays using the Riboquant kit (BD Pharmingen,
San Diego, CA) following the instructions of the supplier. The
quantity of protected mRNA was determined using a PhosphorI-
mager and ImageQuant software (all from Molecular Dynamics,
Sunnyvale, CA).
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